2012
DOI: 10.7314/apjcp.2012.13.5.2175
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Matrix Metalloproteinase-2, but not Caspase-3, Facilitates Distinction between Benign and Malignant Thyroid Follicular Neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
28
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 28 publications
(28 citation statements)
references
References 28 publications
(39 reference statements)
0
28
0
Order By: Relevance
“…Caspase-3: sections were subjected to staining with the primary rabbit polyclonal anti-caspase-3 antibody (Thermo Scientific, Lab Vision, USA) [20] .…”
Section: Immunohistochemical Studymentioning
confidence: 99%
“…Caspase-3: sections were subjected to staining with the primary rabbit polyclonal anti-caspase-3 antibody (Thermo Scientific, Lab Vision, USA) [20] .…”
Section: Immunohistochemical Studymentioning
confidence: 99%
“…So, it might the high expression of MMPs genes allow the remodeling of extracellular matrix to increase the invasive potential of cancer cells (Gonzalez-Arriaga et al, 2012). MMP-2 is known as gelatinase A that degrades the type IV collagen and gelatin, which are the main constituents of basal lamina and might affect early events in carcinogenesis and tumor invasion and/or metastasis (Sanii et al, 2012). The MMP-2 gene locates on chromosome 16 at q13-21 and has thirteen exons (Saeed et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…[2] Thyroid lesions with follicular growth pattern are composed of a wide range including benign adenomatous nodule, Follicular Thyroid Adenoma (FTA), Follicular Thyroid carcinoma (FTC) and Follicular variant of Papillary Thyroid Carcinoma (FVPTC). [3][4][5] FTA, FTC and FVPTC are well encapsulated lesions sharing many imaging, cytologic and histologic features [5][6][7][8] .…”
Section: Introductionmentioning
confidence: 99%
“…[5,10] One of the most challenging tasks in pathologic evaluation of thyroid follicular pattern lesion is distinction between FTC and FTA as a common benign thyroid nodule. [4] Diagnosis of carcinoma is based on the presence of capsular, vascular or extra thyroid tissue invasion or nodal or distant metastasis. [5,8,[10][11][12] Different tools such as IHC and molecular profiling have been used to differentiate between benign and malignant follicular neoplasms or differentiating malignant tumor subtypes, [4,9,13] including some angiogenesis factors.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation